Biomarin Pharmaceutical Inc (BMRN)
Gross profit margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 2,516,129 | 2,437,364 | 2,343,614 | 2,273,680 | 2,173,235 | 2,069,240 | 1,952,326 | 1,889,616 | 1,789,135 | 1,724,903 | 1,670,919 | 1,612,370 | 1,532,182 | 1,448,331 | 1,412,290 | 1,375,760 | 1,371,685 | 1,354,471 | 1,311,358 | 1,336,163 |
| Revenue (ttm) | US$ in thousands | 3,094,001 | 3,063,608 | 2,950,227 | 2,853,915 | 2,752,809 | 2,588,398 | 2,471,644 | 2,419,226 | 2,310,557 | 2,234,572 | 2,173,095 | 2,096,039 | 2,008,311 | 1,911,709 | 1,879,604 | 1,846,275 | 1,848,588 | 1,916,630 | 1,844,422 | 1,860,435 |
| Gross profit margin | 81.32% | 79.56% | 79.44% | 79.67% | 78.95% | 79.94% | 78.99% | 78.11% | 77.43% | 77.19% | 76.89% | 76.92% | 76.29% | 75.76% | 75.14% | 74.52% | 74.20% | 70.67% | 71.10% | 71.82% |
September 30, 2025 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,516,129K ÷ $3,094,001K
= 81.32%
Peer comparison
Sep 30, 2025
Company name
Symbol
Gross profit margin
Biomarin Pharmaceutical Inc
BMRN
81.32%
Arrowhead Pharmaceuticals Inc
ARWR
68.33%
Regeneron Pharmaceuticals Inc
REGN
85.39%